Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130162) titled 'Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer' on Aug. 12.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Breast Cancer
Intervention:
Diagnostic Test: Measurement of serum PIGU protein concentrations of patients and controls by Enzyme-Linked Immunosorbent Assay (ELISA)
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 96
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130162
Published by HT Digital Content Services with permission from Health Daily Digest....